Upregulation of CIRP by its agonist prevents the development of heart failure in myocardial infarction rats

Jingjing Zhang,Tao Liu,Yanzhao Wei,Jianye Peng,Gaofeng Zeng,Peng Zhong
DOI: https://doi.org/10.1186/s12872-024-03852-9
IF: 2.174
2024-03-29
BMC Cardiovascular Disorders
Abstract:Downregulated expression of cold-inducible RNA binding protein (CIRP), a stress-response protein, has been demonstrated in the hearts of patients with heart failure (HF). However, whether CIRP plays a critical role in the pathogenesis of HF remains unknown. Zr17-2 is a recently identified CIRP agonist, which can enhance the expression of CIRP in hearts. Herein, we evaluated the effects of zr17-2 on the development of HF in a rat model of myocardial infarction (MI).
cardiac & cardiovascular systems
What problem does this paper attempt to address?